Hamill John P. - Insider Non-Derivative Transactions at Aprea Therapeutics, Inc. (APRE) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 10, 2025, Hamill John P.'s relationship to Aprea Therapeutics, Inc. (APRE) is Officer (SrVP/CFO/Prin Fin & Acct Ofcr), and currently has 27,733 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other APRE insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Hamill John P. - Insider Non-Derivative Transactions of APRE Common Stock

Hamill John P. - Insider Non-Derivative Transactions at APRE

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 11, 2025	P -- (Common Stock)	5000	1.17	27733
Mar 28, 2025	Acquisition -- (Common Stock)	3365	0	22733
Oct 12, 2024	P -- (Common Stock)	50	2.46	19368
Oct 11, 2024	P -- (Common Stock)	450	2.61	19318
Mar 29, 2024	Acquisition -- (Common Stock)	3365	0	18868
Mar 14, 2024	P -- (Common Stock)	1010	7.29	15503
Feb 28, 2023	Acquisition -- (Common Stock)	1000	5.25	14493
Jan 31, 2023	Acquisition -- (Common Stock)	269879	0	269879